Armata Pharmaceuticals ARMP
NYSE ARMP
$5.52 -0.30 (-5.15%)
As of: Sep 9, 2026 · 3:59 PM EDT

Armata Pharmaceuticals (ARMP) Preferred Dividend Payments (2013 - 2016)

Armata Pharmaceuticals' (ARMP) quarterly Preferred Dividend Payments came in at $133000.0 in Q2 2016, down 92.72% year-over-year from $1.8 million in Q3 2015, and down 92.29% quarter-over-quarter from $1.7 million in Q1 2016.

Analysis

Armata Pharmaceuticals (ARMP) Preferred Dividend Payments (2013 - 2016) Analysis & Trends

Armata Pharmaceuticals has disclosed Preferred Dividend Payments across 4 years of filings, most recently posting $133000.0 for Q2 2016.

  • In Q2 2016, Preferred Dividend Payments fell 92.72% year-over-year to $133000.0; the TTM figure through Dec 2016 stood at $1.9 million (down 81.92% YoY), while the FY2016 annual figure was $1.9 million, down 81.92% from the prior year.
  • Preferred Dividend Payments came in at $133000.0 for Q2 2016 at Armata Pharmaceuticals, down from $1.7 million in the prior quarter.
  • In the past five years, Preferred Dividend Payments ranged from a high of $7.2 million in Q3 2015 to a low of $103000.0 in Q2 2013.
  • Average Preferred Dividend Payments over 4 years is $1.1 million, with a median of $323000.0 recorded in 2014.
  • Year-over-year, Preferred Dividend Payments jumped 2117.65% in 2015 and plunged 92.72% in 2016.
  • Over 4 years, Preferred Dividend Payments stood at $229000.0 in 2013, then jumped by 44.1% to $330000.0 in 2014, then jumped by 187.58% to $949000.0 in 2015, then slumped by 85.99% to $133000.0 in 2016.
  • Per Business Quant data, the three most recent Preferred Dividend Payments figures were $133000.0 in Q2 2016, $1.7 million in Q1 2016, and $949000.0 in Q4 2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn -
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn -
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn -
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn -
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn -
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn -
10 Armata Pharmaceuticals 203.22 Mn 179.22 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2016 133,000.00
Mar 31, 2016 1.73 Mn
Dec 31, 2015 949,000.00
Sep 30, 2015 7.16 Mn
Jun 30, 2015 1.83 Mn
Mar 31, 2015 338,000.00
Dec 31, 2014 330,000.00
Sep 30, 2014 323,000.00
Jun 30, 2014 318,000.00
Mar 31, 2014 314,000.00
Dec 31, 2013 229,000.00
Sep 30, 2013 286,000.00
Jun 30, 2013 103,000.00